Pharmacokinetics and safety of treatment with paracetamol in children and adults with spinal muscular atrophy and cerebral palsy - Paracetamol study in patients with low muscle mass

Copenhagen Neuromuscular Center0 个研究点目标入组 24 人开始时间: 2018年7月11日最近更新: 2021年11月29日

适应症

试验速览

暂无简介。

•-Patients: Men, women and children diagnosed with/biochemically verified SMA and CP
•-Patients admitted to the ICU: Men, women, children diagnosed with/biochemically verified SMA and CP
•-Healthy controls: Need to be healthy, evaluated by the investigator.
•oChildren: 6-18 years
•oAdult patients: 18-45 years
•oHealthy controls: 18-45 years
•oICU-admitted patients: 6-45 years
•-Signed informed consent to participation in the trial
•Are the trial subjects under 18? yes
•Number of subjects for this age range: 12
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 12
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•-Inability to understand the purpose of the trial or cooperate in the conduction of the experiments.
•oFor the children this will concern of course the parents or the guardians of the child.
•-Competing conditions at risk for compromising the results of the study.
•-Participation in other trials that may interfere with the results.
•-Intake of medications that may interfere with the results, evaluated by investigator.
•-Pregnancy and breastfeeding.

发起方

Copenhagen Neuromuscular Center